The peptide landscape is changing fast and retatrutide is at the center of the conversation.
In this episode, Mike Sheffer and Max Plasencia discuss the latest developments surrounding a new long-acting retatrutide-related product, including the reported challenges around naming, regulation, pharmaceutical competition, and where the product could potentially fit into the future peptide market.
Mike and Max then answer viewer questions about GLP-1 weight-loss compounds, peptide tolerance, receptor sensitivity, weight-loss plateaus, and the importance of using the minimum effective approach rather than aggressively increasing doses. They also discuss concerns around muscle loss during rapid weight loss and why maintaining muscle is important when pursuing long-term body-composition goals.
Another major part of the conversation focuses on histamine and allergic-type reactions to peptides. Max shares his personal experimentation with different injection locations and reconstitution concentrations after experiencing reactions to tesamorelin. Mike adds his own experiences with compounds including MOTS-c and discusses possible factors such as injection site, concentration, mast-cell activity, and individual sensitivity.
The episode also covers an important community question about alternating retatrutide and tirzepatide, including the differences between their receptor activity and why the hosts discuss alternative approaches such as amylin-based compounds.
Later, Mike and Max compare nasal vs. injectable administration of C-MAX and Selank, discussing convenience and the different effects they associate with each route.
Finally, they break down HGH vs. IGF-1, including their different mechanisms, potential benefits and risks, blood glucose considerations, muscle growth, recovery, and why monitoring IGF-1 levels can be useful when discussing growth-hormone-related compounds.
In This Episode:
-New retatrutide developments
-Retatrutide and pharmaceutical regulation
-The future of long-acting peptides
-GLP-1 receptor tolerance
-Weight-loss plateaus
-Tirzepatide vs. retatrutide
-Cagrilintide / amylin receptor discussion
-Peptide histamine reactions
-Tesamorelin reactions
-MOTS-c reactions
-Injection site and peptide reactions
-Peptide reconstitution
-C-MAX vs. Selank
-Nasal vs. injectable peptides
-HGH vs. IGF-1
-IGF-1 and blood glucose
-Muscle growth and recovery
-Blood work and biomarker monitoring
-Responsible peptide use
🎙️ Hosts
Mike Sheffer, Max Plasencia
About Weekly Pep-Talk: Weekly Pep-Talk is a podcast covering peptides, longevity, GLP-1s, fat loss, bodybuilding, performance enhancement, recovery, biohacking, and health optimization.
New episodes every week.
Buy Peptides online at Prime Longevity Peptides. Enter code:welcome20 for 20% off your first order:https://primelongevitypeptides.com
Join Our Facebook Community Group: GLP & Peptide Warriors: Science-Backed &Supported
Instagram prime_longevity_protocol
Email - info@primelongevityprotocol.com
INSTAGRAM: mikesheffer_
FREE Skool: https://www.skool.com/mikes-pep-talk-...
SPOTIFY: https://open.spotify.com/show/2ADXM9h...
APPLE PODCAST: https://podcasts.apple.com/us/podcast...
WEBSITE: https://primelongevitypeptides.com
